I agree that this site is using cookies. You can find further informations here.
X
Loi, Sherene
466  results:
Search for persons X
?
1

Targeting HER2-mutant metastatic cervical cancer with nerat..:

Friedman, Claire F. ; D'Souza, Anishka ; Bello Roufai, Diana...
Gynecologic Oncology.  181 (2024)  - p. 162-169 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Towards targeting the breast cancer immune microenvironment:

Harris, Michael A. ; Savas, Peter ; Virassamy, Balaji...
Nature Reviews Cancer.  24 (2024)  8 - p. 554-577 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Research autopsy programmes in oncology: shared experience ..:

Geukens, Tatjana ; Maetens, Marion ; Hooper, Jody E...
The Journal of Pathology.  263 (2024)  2 - p. 150-165 , 2024
Link: https://doi.org/10.1002/..
 
?
4

NVTG-07 SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF TRA..:

Anders, Carey ; Loi, Sherene ; Hamilton, Erika...
Neuro-Oncology Advances.  6 (2024)  Supplement_1 - p. i25-i25 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Annotation-efficient deep learning for breast cancer whole-..:

Perera, Rashindrie ; Savas, Peter ; Senanayake, Damith...
Communications Engineering.  3 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

The anti-cancer immune response in breast cancer: current a..:

Rayson, Victoria C. ; Harris, Michael A. ; Savas, Peter...
Trends in Cancer.  10 (2024)  6 - p. 490-506 , 2024
Link: https://doi.org/10.1016/..
 
?
7

CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated neg..:

House, Imran G. ; Derrick, Emily B. ; Sek, Kevin...
Cell Reports.  43 (2024)  2 - p. 113793 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Embracing cancer complexity: Hallmarks of systemic disease:

Swanton, Charles ; Bernard, Elsa ; Abbosh, Chris...
Cell.  187 (2024)  7 - p. 1589-1616 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Cortés, Javier ; Hurvitz, Sara A. ; Im, Seock-Ah...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
10

Society for Immunotherapy of Cancer (SITC) recommendations ..:

Luke, Jason J ; Davar, Diwakar ; Andtbacka, Robert H...
Journal for ImmunoTherapy of Cancer.  12 (2024)  4 - p. e008378 , 2024
Link: https://doi.org/10.1136/..
 
?
11

A systematic review and meta‐analysis of the impacts of ger..:

Lingaratnam, Senthil ; Shah, Mahek ; Nicolazzo, Joseph...
Clinical and Translational Science.  17 (2024)  5 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
12

Combined PARP and WEE1 inhibition triggers anti-tumor immun..:

Teo, Zhi Ling ; O'Connor, Mark J. ; Versaci, Stephanie...
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Immunotherapy in Early-Stage Triple-Negative Breast Cancer:..:

Dixon-Douglas, Julia ; Loi, Sherene
Current Treatment Options in Oncology.  24 (2023)  8 - p. 1004-1020 , 2023
Link: https://doi.org/10.1007/..
 
?
14

CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated neg..:

House, Imran G. ; Derrick, Emily B. ; Sek, Kevin...
Cell Reports.  42 (2023)  8 - p. 113014 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Health-related quality of life with pembrolizumab plus chem..:

Cescon, David W ; Schmid, Peter ; Rugo, Hope S...
JNCI: Journal of the National Cancer Institute.  116 (2023)  5 - p. 717-727 , 2023
Link: https://doi.org/10.1093/..
 
1-15